Technical brief | 29 June 2021 COVID-19 MSF analysis of EU communications to TRIPS Council on COVID-19 IP waiver proposal
Technical brief | 27 May 2021 COVID-19 India and South Africa proposal for WTO waiver from IP protections for COVID-19-related medical technologies
Technical brief | 27 May 2021 COVID-19 Analysis of EU position on compulsory licensing and TRIPS waiver in the COVID-19 pandemic
Technical brief | 26 May 2021 COVID-19 Compulsory licenses, the TRIPS Waiver, and access to COVID-19 medical technologies
Technical brief Technical brief | 09 March 2021 COVID-19 Canada MSF Canada Briefing Note: WTO COVID-19 TRIPS Waiver
Technical brief | 26 January 2021 COVID-19 United States of America Transparency Matters: Disclosing the Costs of Publicly Funded Research & Development for COVID-19 Medical Tools and Beyond
